Arena Pharmaceuticals Inc
* Arena Pharmaceuticals - Cash and cash equivalents as of June 30, 2017 of $130.8 million, which includes about $0.2 million of cash held by beacon discovery Source text: [bit.ly/2t1agiY] Further company coverage:
July 11th, 2017 | 17:28 PM healthcare 279
Arena Pharmaceuticals Inc
* Arena Pharmaceuticals - Cash and cash equivalents as of June 30, 2017 of $130.8 million, which includes about $0.2 million of cash held by beacon discovery Source text: [bit.ly/2t1agiY] Further company coverage: